References
- BMJ and Royal Pharmaceutical Society. Coumarins and phenindione. British National Formulary. UK, 2013. http://www.medicinescomplete.com/mc/bnf/current/PHP1485-coumarins-and-phenindione.htm. Accessed April 30, 2013
- Connock M, Stevens C, Fry-Smith A, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess 2007;11: iii-iv, ix-66
- Summary of 2012/13 QOF changes. United Kingdom: NHS Employers, 2012. http://www.nhsemployers.org/SiteCollectionDocuments/Summary%20of%20QOF%20changes%20for%202012-13%20-ja21111.pdf. Accessed April 30, 2013
- Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with Warfarin, 4th edn. Br J Haematol 2011;154:311-24
- Gallagher A, Setakis A, Plumb J, et al. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost 2011;106:968-77
- Heneghan C, Ward A, Perea R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012;379:322-34
- Bloomfield HA, Krause A, Greer N, et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med 2011;154:472-82
- Dolan G, Smith LA, Collins S, et al. Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature. Curr Med Res Opin 2008;24:1459-72
- Heneghan C, Alonso-Coello P, Garcia-Alaminio JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006;367:404-11
- Garcia-Alamino JM, Ward AM, Alonso-Coello P, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev 2010;14:CD003839
- Brown A, Wells P, Jaffey J, et al. Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness. Technology report No 72. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007
- Gailly J, Gerkens S, Van Den Bruel A, et al. Use of point-of care devices in patients with oral anticoagulation: a Health Technology Assessment. Reports vol 117C. Brussels: Belgian Health Care Knowledge Centre, 2009
- Bayer Plc. Submission to NICE: Single technology appraisal of Rivaroxaban. London, 2011. http://www.nice.org.uk/nicemedia/live/13308/57753/57753.pdf. Accessed April 30, 2013
- National Institute for Health and Clinical Excellence. Costing template: Dabigatran etexilate for the prevention of stroke and systemic embolism in people with atrial fibrillation. London, 2012. http://guidance.nice.org.uk/TA249/CostingTemplate/xls/English. Accessed April 30, 2013
- Gardiner C, Williams K, Longair I, et al. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. Br J Haematol 2006;132:598-603
- Parry D, Bryan S, Gee K, et al. Patient costs in anticoagulation management: a comparison of primary and secondary care. Br J Gen Pract 2001;51:972-6
- Department of Health. NHS Reference Costs 2010/11. London, 2012. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_131140. Accessed April 30, 2013
- Roche Diagnostics. Coaguchek XS System. England, 2012. https://shop.coaguchek.com/buy/xs-system?language=en. Accessed April 26, 2013
- Personal Social Services Research Unit. Unit Costs of Health and Social Care. UK, 2011. http://www.pssru.ac.uk/project-pages/unit-costs/2011/index.php. Accessed April 30, 2013
- Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing 2009;38:27-32
- Berg J, Lindgren P, Nieuwlaat R, et al. Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Qual Life Res 2010;19:381-90
- Robinson A, Thomson R, Parkin D, et al. How patients with atrial fibrillation value different health outcomes: a standard gamble study. J Health Serv Res Policy 2001;6:92-8
- Hallan S, Asberg A, Indredavik B, Wideroe TE. Quality of life after cerebrovascular stroke: a systematic study of patients’ preferences for different functional outcomes. J Intern Med 1999;246:309-16
- Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics 2006;24:1021-33
- Lacey EA, Walters SJ. Continuing inequality: gender and social class influences on self perceived health after a heart attack. J Epidemiol Community Health 2003;57:622-7